5-MeO-MPMI
From Infogalactic: the planetary knowledge core
![]() |
|
Systematic (IUPAC) name | |
---|---|
(R)-3-(N-methylpyrrolidin-2-ylmethyl)-5-methoxyindole
|
|
Identifiers | |
CAS Number | 143321-57-7 ![]() |
PubChem | CID: 9881324 |
ChemSpider | 8057000 ![]() |
ChEMBL | CHEMBL137485 ![]() |
Chemical data | |
Formula | C15H19N2O |
Molecular mass | 243.323 g/mol |
|
|
|
|
![]() ![]() |
5-MeO-MPMI (also known as 5-Methoxy-N-methyl-(α,N-trimethylene)tryptamine) is a tryptamine derivative that is a psychedelic drug. It was first developed by the team led by JE Macor in 1992,[1] and subsequently investigated by the team led by David Nichols from Purdue University in the late 1990s. This compound produces psychedelic-appropriate responding in animal tests with a similar potency to the amphetamine-derived psychedelic DOI, and has two enantiomers, with only the (R)-enantiomer being active.[2]
See also
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
Categories:
- Pages with reference errors
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Drugs with no legal status
- Psychedelic tryptamines
- Designer drugs